Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:

Content type

Project (27)


Australia (1)
Austria (6)
Belgium (21)
Burkina Faso (1)
Czech Republic (3)
Denmark (8)
Finland (9)
France (18)
Gabon (1)
Germany (25)
Greece (1)
Hungary (1)
Ireland (3)
Israel (1)
Italy (17)
Luxembourg (5)
Netherlands (27)
Norway (1)
Poland (1)
Portugal (1)
Senegal (1)
Slovenia (3)
Spain (13)
Sweden (15)
Switzerland (15)
United Kingdom (29)
United States (10)

Advanced search

Search projects and results

Results 1 - 10 of 27
12 3 > 
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.
ID: 115797
Start date: 2015-11-01, End date: 2022-10-31
Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findings from in vitro and animal models into effective clinical interventions. INNODIA aims to achieve a break-through in the way in which we...
Programme: H2020-EU.
Record Number: 209863
Last updated on: 2017-03-27
Ebola Virus: Modern Approaches for developing  bedside Rapid Diagnostics
ID: 115843
Start date: 2015-02-01, End date: 2018-01-31
The current Ebola Virus Disease (EVD) outbreak has caused more than 5000 deaths within a few months in West Africa (Guinea, Sierra Leone and Liberia being the most severely affected countries), including numerous healthcare workers. It is now a serious public health crisis of...
Programme: H2020-EU.
Record Number: 209451
Last updated on: 2017-03-27
Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management
ID: 777365
Start date: 2017-09-01, End date: 2022-08-31
Drug safety assessment is a knowledge-intensive process that demands advancement in data handling methods and tools for facilitating data sharing, mining, analysis and predictive modelling. This need is not restricted to any specific type of data and real advancement...
Programme: H2020-EU.
Record Number: 212141
Last updated on: 2017-12-06
Liver Investigation: Testing Marker Utility in Steatohepatitis
ID: 777377
Start date: 2017-11-01, End date: 2022-10-31
Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, Non-Alcoholic Fatty Liver Disease (NAFLD) is an increasingly common cause of advanced liver disease that is characterized by substantial...
Programme: H2020-EU.
Record Number: 212225
Last updated on: 2017-10-31
Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes
ID: 115890
Start date: 2015-07-01, End date: 2017-12-31
Progress in the life sciences and related technologies offer great potential for therapeutic benefits to patients in need. However, major adaptations to current paradigms of bringing medicines to patients are required in order to realize that potential and to address important...
Programme: H2020-EU.
Record Number: 209455
Last updated on: 2017-03-27
Models Of Patient Engagement for Alzheimer’s Disease
ID: 115985
Start date: 2016-12-08, End date: 2019-11-30
The MOPEAD consortium has proposed a programme of work carefully aligned to the objectives of IMI2 Call to deliver a step-change in AD-related patient engagement (PE) strategies and a paradigm shift in early stage care. It aims to improve patient engagement in two categories:...
Programme: H2020-EU.3.1.7.
Record Number: 209465
Last updated on: 2017-03-27
Patient Preferences in benefit risk assessments during the drug life cycle
ID: 115966
Start date: 2016-11-16, End date: 2021-09-30
The PREFER project will deliver an overview and evaluation of preference elicitation methods to be applied in the entire drug life cycle, i.e. in the early stages of identifying medical needs, in clinical testing, to guide decisions on reimbursement and to make decisions on...
Programme: H2020-EU.3.1.7.
Record Number: 209460
Last updated on: 2017-08-05
Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33
ID: 115976
Start date: 2016-11-01, End date: 2021-10-31
Alzheimer’s disease (AD) is an age-related chronic neurodegenerative disease with four main pathological changes in the brain: amyloid plaques, fibrillary tau tangles, inflammation and neuronal loss. Phagocytes around amyloid plaques in late onset AD (LOAD) may be neurotoxic...
Programme: H2020-EU.3.1.7.
Record Number: 209462
Last updated on: 2017-03-27
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
ID: 115916
Start date: 2016-04-01, End date: 2019-03-31
The current nosology of neuropsychiatric disorders allows for a pragmatic approach to treatment choice, regulation and clinical research. However, without a biological rationale for these disorders, drug development has dramatically stagnated in the past decades. In a...
Programme: H2020-EU.
Record Number: 209457
Last updated on: 2017-05-17
Vaccine lot to Vaccine lot comparison by consistancy testing
ID: 115924
Start date: 2016-03-01, End date: 2021-02-28
Lot release testing of established vaccines relies on using animal models. Many of these models were developed decades ago and reflect the level of product knowledge, production technology and quality management in those days. Current production techniques are optimised...
Programme: H2020-EU.
Record Number: 209456
Last updated on: 2017-07-03
12 3 > 
List retrieved on: 2017-12-13
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top